Bladder Cancer Canada News and Stories

The Alberta Health Services Cancer Strategic Clinical Network is conducting a “patient experience” study to gain knowledge about the current services available for bladder cancer patients in Alberta. They will be identifying what is working well and what is not working so well for patients. This

Dr. Michael A.S. Jewett (University of Toronto and Princess Margaret Cancer Centre) will receive the Exceptional Leadership in Patient Involvement in Cancer award for his long-standing commitment to and advocacy for greater patient involvement in clinical research prioritization, rese

As part of its mission, Bladder Cancer Canada (BCC) is committed to furthering research into the prevention, diagnosis and treatment of bladder cancer. Thanks primarily to funds raised from the annual Awareness Walk, BCC has been able to award $50,000 for two years in a row to research investigators

Each year, the Canadian International Freight Forwarders Association (CIFFA) awards the Donna Letterio Leadership Award in memory of former CIFFA President Donna Letterio, who passed away in August 2013. The award recognizes a woman in the global freight logistics sector who has demonstrat

This year, Bladder Cancer Canada (BCC) is co-funding a $50,000 grant for bladder cancer research in partnership with the Canadian Urological Association Scholarship Foundation (CUASF).  The CUASF is a scholarship fund that was set up by the Canadian Urological Association and its Members, and has

Photo credit: John Packman Bladder Cancer Canada’s co-founders, Jack Moon and David Guttman, have been named recipients of the Meritorious Service Medal (MSM). This is a high-level and prestigious award which is given with great discretion. It enables the Governor General, on behalf of al

In 2016 Bladder Cancer Canada funded the first study to comprehensively produce quality indicators for bladder cancer. Over time these benchmarks will provide the opportunity to improve consistency of care and better outcomes for patients. Though developed in Canada, these indicators can potentially